News › Industry News, News

Ozempic, Mounjaro Lawsuits Consolidated in Federal Multidistrict Litigation

February 6, 2024
Medical law: books, gavel and stethoscope

A federal panel has consolidated at least 55 lawsuits against pharmaceutical companies Novo Nordisk and Eli Lilly into a multidistrict litigation in the Eastern District of Pennsylvania.

The lawsuits claim that these companies did not adequately warn people about the severe side effects associated with a class of prescription drugs including Ozempic and Mounjaro.

Plaintiffs’ lawyers anticipate filing up to 10,000 lawsuits related to Ozempic and similar drugs as part of the MDL.

Read more at Drugwatch.com >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics’ Skinvive by Juvéderm Receives FDA Approval for the Improvement of Neck Appearance
    • Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
    • MedSafe Becomes Gold Vendor Affiliate with the American Med Spa Association
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics